Most VHH phage-display projects use 2–4 rounds of panning as an initial working range, with 3 rounds often serving as a practical starting point. The right number is not fixed: it depends on the target, library, selection conditions, and whether enrichment is producing useful, target-specific candidates. We recommend assessing the output after each round rather than continuing automatically to a preset total. The goal is to recover diverse VHH candidates that bind the intended target—not simply to maximize enrichment.
Click here to get more.
In phage display, a panning round generally involves exposing a VHH-displaying phage pool to a target, washing away unbound or weakly retained phage, recovering retained phage, and amplifying them for the next selection. Repeating this process can increase the proportion of phage associated with the target under the selection conditions. However, the resulting pool reflects both the biology of binding and the technical details of the assay.
Target format is one important consideration. A purified protein immobilized on a surface may expose different binding sites from the same protein in solution or in a native complex. Immobilization, tag sequences, blocking reagents, and the surface itself can also influence which phage are retained. For veterinary projects, the intended use may further change the selection strategy: a reagent for detecting a pathogen antigen in a biological sample may need to recognize the target in a different context than a research reagent tested only against purified protein.
Enrichment means that the recovered pool shows increased recovery or binding relative to an earlier pool or an appropriate control. It is a useful signal for deciding whether to continue, but it does not by itself prove that individual VHHs are specific, functional, or suitable for an application. A pool can become enriched for phage that recognize a tag, a capture reagent, or a surface component. Individual clone screening and follow-up validation are therefore essential.
Before panning begins, clarify what counts as a successful VHH. Specify the target form, relevant species or variants, and the intended downstream use, such as research detection or veterinary diagnostic development. If recognition of a native or disease-associated form matters, the selection and screening plan should account for that requirement. Clear success criteria make it easier to judge whether another round is useful.
Plan how to compare target-associated recovery with background recovery. Depending on the target and selection format, useful controls may include the immobilization surface, an unrelated protein, a tag, or a capture reagent. The appropriate controls vary by project, so they should be chosen to address likely sources of nonspecific binding rather than added as a generic checklist. Recording input and recovered phage consistently also makes round-to-round interpretation more meaningful.
Use the results from each round to decide whether to continue, change conditions, or move to individual-clone screening. For example, if target-associated recovery improves while control-associated recovery remains low, another round may help concentrate useful binders. If background recovery rises alongside target recovery, additional rounds under unchanged conditions may reinforce unwanted binding rather than solve it. In that situation, consider adjusting blocking, washing, target presentation, or counter-selection before simply adding another cycle.
For more information, please visit NBbiolab.
After the selected number of rounds, test individual clones using an assay suited to the project. Evaluate binding to the intended target alongside appropriate negative controls, and confirm that the signal is not explained by tags, surfaces, or assay reagents. Where relevant, assess cross-reactivity against related species or target variants. The number of panning rounds should be treated as a route to candidates, while the clone-level data determine whether those candidates meet project needs.
Stopping after fewer rounds may be reasonable when the pool shows useful target-associated enrichment and further selection risks narrowing the candidate set without improving specificity. Early screening can also be informative when preserving diversity is important. A low apparent enrichment result does not automatically mean that more rounds are needed; it may indicate that the target presentation, recovery method, or assay conditions need review.
An additional round may be worth considering when the pool has not yet produced a clear target-associated signal, background remains controlled, and the selection conditions are still appropriate. It may also help when the initial pool is diverse and the project requires stronger selection under defined conditions. The decision should be based on comparative results and project objectives, not on a fixed expectation that every campaign must reach the same round count.
When evaluating a service, ask how the provider will select a starting round range, monitor enrichment, and decide whether to continue or modify the campaign. Confirm what information and materials are needed from your team, including target format, species or variant requirements, and intended application. It is also useful to clarify what outputs are included, such as recovered pools, sequence information, clone screening, or follow-up characterization. Scope and deliverables should be agreed before the project starts, since service packages can differ.
At NBbiolab, we can discuss a Phage Display VHH Discovery Service in relation to your target and project goals. Sharing the target’s format, relevant veterinary species, intended use, and any known assay constraints helps establish a more appropriate selection and evaluation plan. We avoid treating a fixed number of rounds as a guarantee of success; the round strategy should be aligned with the evidence generated during the campaign. Contact our team to discuss the project scope and the information needed for an initial assessment.
For VHH screening, 2–4 rounds is a useful planning range, and 3 rounds is a reasonable starting point for discussion—not a universal requirement. Continue only when round-to-round results support it, and reconsider conditions if background binding rises or the target signal remains unclear. After panning, use individual-clone screening and application-relevant validation to determine whether the recovered VHHs are suitable. To plan the next step, define the target format, controls, intended veterinary use, and service deliverables with your discovery provider.
Want more information on How Many Panning Rounds Are Needed for VHH Screening?? Feel free to contact us.